Crural Arteries PTA in Patients with Diabetes

Czech version

Authors: P. Šeliga; J. Vaško; P. Kováč; M. Šimko ^*
Authors‘ workplace: Oddelenie cievnej chirurgie FNsP Prešov, Slovenská republika, primár: MUDr. J. Vaško ; Oddelenie rádiodiagnostiky FNsP Prešov, Slovenská republika, primár: MUDr. M. Šimko ^*
Published in: Rozhl. Chir., 2009, roč. 88, č. 8, s. 444-450.
Category: Monothematic special - Original

Overview

Aim:
The authors analyse the patients hospitalized with a neuroischemic diabetic foot. They evaluate experiences and results of the crural arteries percutaneous transluminal angioplasty (PTA) in the diabetic patients.

Method:
It is a retrospective analysis of the patients hospitalized during years 2005-2008 at the Department of Vascular Surgery of the Teaching Hospital J. A. Reiman Prešov with the diabetic foot. During the study period 265 hospitalization in 205 patients were registered for complications of the diabetic foot. PTA of the crural arteries was performed on 74 lower extremities in 68 patients. 133 crural arteries were revascularized in this group of the patients. Indication for execution of the crural arteries PTA in the diabetic patients was critical limb ischemia on 68 revascularized lower extremities (91.9%).

Results:
Technical success (residual stenosis no more than 30%, unobstructed revascularized crural artery to periphery) was achieved on 93 revascularized crural arteries (69.92%). They háve control examination minimally 12 months after PTA in 54 revascularized lower extremities of the 68 patients with the neuroischemic diabetic foot. From this subset of the patients 28 lower extremities (51.85%) are healed according to clinical examination, on 7 lower extremities (12.96%) clinical signs of critical limb ischemia remain, 10 times (18.52%) low amputation was performed and 9 times (16.67%) high amputation was executed.

Conclusion:
The authors believe that PTA of the crural arteries is safe and effective method of critically ischemic diabetic foot revascularization. If revascularization is successful, it can effectively contributes to the lower extremity salvage of the patient with neuroischemic diabetic foot.

Key words:
diabetic foot – critical limb ischemia – percutaneous transluminal angioplasty

Sources

1. Adam, D. J., Beard, J. D., Cleveland, T., Bell, J., Bradbury, A. W., Forbes, J. F., et al. Basil trial participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet, 2005, č. 366, s. 1925–1934.

2. Babčák, M., Merčiaková, M. Prevalencia diabetes mellitus 2. typu a jeho komplikácií na internej klinike I. Zdravotníctvo a sociálna práca, 2006, č. 3, s. 7–11.

3. Babčák, M., Racz, O., et al. Diabetes mellitus a artériová hypertenzia. DAH 2008, Prešov, ISBN 978-80-969865-0-7.

4. Graziani, L., Silvestra, A., Bertone, V., Manara, E., Andreini, R., Sigala, A., Mingardi, R., Degiglio, R. Vascular involvment in diabetic subjects with ischemic foot ulcer: A new morphologic categorization of disease severity. Eur. J. Vasc. Endovasc. Surg., 2007, č. 33, s. 453–460.

5. Faglia, E., Dalla Paola, L., Clerici, G., Clerissi, J., Graziani, L., Fusaro, M., et al. Peripheral angioplasty as the first-choice revascularization procedúre in diabetic patients with critical limb ischemia: Prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur. J. Vasc. Endovasc. Surg., 2005, č. 29, s. 620–627.

6. Dormandy, J. A, Rutherford, R. B., et al. Management of peripheral arterial disease(PAD). TASC Working Group. TransAtlantic Inter-Society Consensus. J. Vasc. Surg., 2000, č. 31, s. 1–96.

7. Kyslan, K., Mýtnik, M., Kyslan, K. ml. Zásady úspešnej prevencie ranej infekcie v chirurgii. Slovenská chirurgia, 2004, č. 1, s. 26–28.

8. Romiti, M., Albers, M., Brochado-Neto, F. C, Durazzo, A. E. S., Pereira, C. A. B., De Lucia, N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J. Vasc. Surg., 2008, č. 47, s. 975–981.

9. Soder, H. K., Manninen, H. L, Jaakkola, P., Matsi, P. J., Räsänen, H. T., Kaukanen, E., Loponen, P., Soimakallio, S. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: Angiographic and clinical results. J. Vasc. Intervent. Radiol., 2000, č. 11, s. 1021–1031.

10. Peregrin, J. H., Kožnar, B. PTA borcových tepen. In : Tošenovský, P., Edmonds, M. E., et al.: Moderní léčba syndrómu diabetické nohy. Praha: Galén, 2004, s. 77–92. ISBN 80-7262-261-7.

11. Mýtnik, M., Daňo, J., Straka, L. Myxoidný liposarkóm. Slovenská chirurgia, 2005, č. 3, s. 24–26.

12. Boroňová, I., Bernasovský, I., Bernasovská, J. Detection of Philadelphia chromosome in patients with chronic myeloid leukemia from the Prešov region in Slovakia (1995-2004). International Journal of Human Genetics, 2007, č. 7 (4), s. 297–301.

13. Boroňová, I., Bernasovský, L., Bernasovská, J., Petrejčíková, E., Bôžiková, A., Soták, M., Sovičová, A., Gabriková, D., Svičková, P., Mačeková, S. Cytogenetics of chronic myeloproliferative disorders. Slovenská antropológia, 2008, č. 11(1), s. 20–27.

14. Bolia, A., Sayers, R. D., Thompson, M. M., Bell, P. R. F. Subintimal and intraluminal recanalization of occluded crural arteries by percutaneous ballon angioplasty. Eur. J. Vasc. Surg., 1994, 8, s. 214–219.

15. Awad, S., Karkos, C. D., Serrachino-inglott, F., Cooper, N. J., Butterfield, J. S., Ashleigh, R., Našim, A. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischemia. Eur. J. Vasc. Endovasc. Surg., 2006, č. 32, s. 51–59.

16. Kyslan, K., Barla, J., Kyslan, K. ml., Stanislayová, M. Syndróm AMS a jeho riešenia. Rozhl. Chir., 2008, č. 5, s. 255–258.

17. Diek, F., Diehm, N., Galimanis, A., Husmann, M., Schmidli, J., Baumgartner, I. Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome. J. Vasc. Surg., 2007, č. 45, s. 751–761.